WritingX
北京深度制耀科技有限公司 · Operations & Productivity
Certification per Microsoft Marketplace.
Evidence tier Source Confirmed · 8 captures on record
What the publisher says
As described on Microsoft Marketplace.
Introducing the latest pharmaceutical development document automation tool by Deep Intelligent Pharma. This innovative solution not only offers pre-set document types but also allows you to customize templates or create new document types according to your needs. By utilizing comprehensive technologies such as GPT-4 Prompt, Example, Langchain, and Embedding, Task Planning, etc, you can generate the required document within one click. You can also import and manage your own Reference library, maximizing the use of past knowledge.
Our cutting-edge EDIT interface enables efficient human-machine interaction. You can choose the sections to revise, upload reference documents, write Prompt Chains, or instruct the machine to search for knowledge from 2021 onwards to update the machine-generated version. For successful Prompt Chains, you can save them to your personal, departmental, or organizational prompt memory for reuse and even control access permissions.
Show the rest of the publisher’s description (2 more lines)
Pre-set document types include Protocol, CSR, safety narrative, Overview, Manuscript, and more. Embrace a whole new working paradigm with an unparalleled and constantly evolving writing assistant at your side.
Deep Intelligent Pharma (DIP) is a global innovative company established in 2017, currently operating simultaneously in various regions such as Singapore, Japan, and China. The company is composed of a group of engineers and pharmaceutical development experts who are passionate about documentation, dedicated to using the power of technology to reduce costs and increase efficiency for pharmaceutical enterprises. Currently, the company is serving more than 500 pharmaceutical companies, biotech, and CRO companies worldwide.
Preview
3 images
Agent build and provenance
See the full provenance
The layer-by-layer build, the evidence behind each claim, the risk basis and the cross-marketplace links are open to any account. Some rows are disclosed, some the source leaves Unknown; a free account shows you which.
Sources
Publisher resources
2 linksLinked repositories
Unknown means this listing does not publish a repository. It is not a statement that the code is closed, and a linked repository is not a claim that the publisher wrote it: the registry computes that relationship privately and does not publish it.
Evidence risk is the share of the build you cannot see before you deploy, not a security rating. Sign in to see the layer-by-layer basis for this band.